Key terms

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ONCY news

Apr 12 11:57am ET Oncolytics Biotech Sets Virtual Annual Meeting by TipRanks Apr 11 2:37pm ET Oncolytics Biotech Eyes Milestone in Breast Cancer Trial by TipRanks Apr 11 7:12am ET Oncolytics submits Type C meeting request to FDA by TipRanks Apr 04 8:22am ET Oncolytics initiated with an Outperform at Raymond James by TipRanks Apr 02 8:27am ET Oncolytics Biotech Showcases at Oncology Event by TipRanks Apr 02 7:48am ET Oncolytics Biotech Showcases at Oncology Conference by TipRanks Mar 09 12:25pm ET Buy Rating Affirmed for Oncolytics Biotech Amidst Promising Pipeline and Advancements in Cancer Treatment Trials by TipRanks Mar 08 4:25pm ET Buy Rating Affirmed on Oncolytics Biotech Amid Progress and Strategic Clinical Trials by TipRanks Mar 08 12:35pm ET Maintaining Buy Rating on ONCY Amidst Promising Clinical Advancements and Partnership Potential by TipRanks Mar 08 7:27am ET Oncolytics Biotech (ONCY) Gets a Buy from RBC Capital by TipRanks Mar 07 4:38pm ET Oncolytics Biotech Shows Promising Cancer Drug Progress by TipRanks Mar 05 7:50am ET Oncolytics Biotech Expands Pancreatic Cancer Study by TipRanks Feb 28 7:40am ET Oncolytics Biotech Spotlights at NeauxCancer Conference by TipRanks Feb 14 9:55am ET Reiterating Buy Rating: Expanding Potential of Pelareorep in Oncolytics Biotech’s Pipeline by TipRanks Feb 14 7:09am ET Oncolytics expands enrollment for GOBLET study evaluating pelareorep by TipRanks Jan 22 1:47pm ET Buy Rating for Oncolytics Biotech Amidst Promising Trials and Anticipated Partnerships by TipRanks
Mar 06 3:00am ET Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning by Newsfile Feb 15 3:00am ET Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments by NewsFile

ONCY Financials

1-year income & revenue

Key terms

ONCY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ONCY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days